Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PLXPLX
24 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PROTALIX BIOTHERAPEUTICS INC

CITADEL ADVISORS LLC holds 334,227 shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $778,749 as of 2026-Q2. This is a new position. PLX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$778,749

Current Shares

334,227

Total Value Change

+$686,749

Total Shares Change

+310,180

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
334,227
-
$778,7490.0%$2.33
34
2026-Q1
Exited
0
-100.0%
$00.0%$2.83
0
2025-Q4
Increased
317,628
+751.4%
$571,7300.0%$1.74
39
2025-Q3
New
37,306
-
$82,8190.0%$2.16
33
2025-Q2
Exited
0
-100.0%
$00.0%$1.54
0
2025-Q1
Decreased
2,818
-98.1%
$7,2140.0%$2.58
0
2024-Q4
Increased
145,787
+59.1%
$274,0800.0%$1.89
23
2024-Q3
Increased
91,658
+396.3%
$93,4910.0%$1.05
24
2024-Q2
Decreased
18,468
-51.1%
$21,6080.0%$1.17
0
2024-Q1
New
37,788
-
$47,6130.0%$1.26
31
2023-Q4
Exited
0
-100.0%
$00.0%$1.78
0
2023-Q3
New
25,614
-
$42,5190.0%$1.66
31
2023-Q2
Exited
0
-100.0%
$00.0%$2.17
0
2023-Q1
Increased
211,548
+70.2%
$444,2510.0%$2.02
36
2022-Q4
Increased
124,307
+112.3%
$170,3010.0%$1.37
25
2022-Q3
Decreased
58,557
-2.3%
$61,0000.0%$1.05
0
2022-Q2
New
59,915
-
$65,0000.0%$1.08
32
2022-Q1
Exited
0
-100.0%
$00.0%$1.05
0
2021-Q4
Increased
29,015
+16.3%
$24,0000.0%$0.85
15
2021-Q3
Decreased
24,945
-78.5%
$34,0000.0%$1.37
0
2021-Q2
Increased
115,886
+634.8%
$221,0000.0%$1.91
25
2021-Q1
New
15,772
-
$70,0000.0%$4.51
32
2020-Q3
Exited
0
-100.0%
$00.0%$3.90
0
2020-Q2
New
24,047
-
$92,0000.0%$3.91
33

Other major holders of PLX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used